Accelerating Bone Repair While Reducing Pain
OsteoCure Therapeutics is a Duke University spinout and JLABS company developing a multifunctional injectable adenosine-based platform to accelerate bone repair while reducing pain. Its lead product OCTA1 targets a $25B market spanning fracture healing, osteoporosis reversal, and bone pain management.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
Healthcare AI platform that converts patient-clinician conversations into structured clinical not...
OpenEvidence is an AI copilot for doctors that helps them make high stakes decisions at the point...
Clinical-stage medical technology company developing neural-engineering implants and platforms to...
Largest national, virtual, in-network psychiatry practice
Implantable neuromodulation device targeting the vagus nerve to treat chronic inflammatory diseas...
Implantable shock absorber (ISA) that unloads the knee, relieves pain, and improves function for ...
